Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.33 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2213750 | 0.94 | GABRA1 (0.44) | GABRA1GABRB2SLC6A2SLC6A4ALDH1A1 | |
| SCHEMBL890397 | 0.85 | CYP3A4 (0.39) | SLC6A2SLC6A4ARALDH1A1CYP3A4 | |
| SCHEMBL9563230 | 0.85 | ALDH1A1 (0.35) | GABRA1GABRB2SLC6A2SLC6A4AR | |
| SCHEMBL17745127 | 0.84 | GABRA1 (0.40) | GABRA1GABRB2ARALDH1A1CYP3A4 | |
| SCHEMBL165995 | 0.83 | GABRA1 (0.46) | GABRA1GABRB2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL6436719 | 0.81 | GABRA1 (0.44) | GABRA1GABRB2ALDH1A1CYP3A4ALOX15 | |
| Ammonia Solution, Strong SCHEMBL7468688 | 0.81 | GABRA1 (0.44) | GABRA1GABRB2ALDH1A1CYP3A4ALOX15 | |
| Hydrochloric Acid SCHEMBL8136588 | 0.81 | GABRA1 (0.44) | GABRA1GABRB2ALDH1A1CYP3A4ALOX15 | |
| SCHEMBL7624528 | 0.81 | GABRA1 (0.44) | GABRA1GABRB2SLC6A2SLC6A4AR | |
| Butane SCHEMBL14335706 | 0.81 | CYP3A4 (0.43) | GABRA1GABRB2SLC6A2SLC6A4AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12209168-B2 | Polyurethane foam premixes containing halogenated olefin blowing agents and foams made from same | HONEYWELL INTERNATIONAL INC. (US) | 2025-01-28 | — | — | US | claimed |
| US-12209168-B2 | Polyurethane foam premixes containing halogenated olefin blowing agents and foams made from same | HONEYWELL INTERNATIONAL INC. (US) | 2025-01-28 | — | — | US | disclosed |
| US-11730717-B1 | Melanin-inspired antimicrobial | The Board of Regents for the Oklahoma Agricultural and Mechanical Colleges (US) | 2023-08-22 | — | — | US | disclosed |
| US-6127460-A | COMPRISING A LIQUID EPOXY RESIN, A LIQUID ALKYLATED DIAMINODIPHENYLMETHANE, AN EPOXIDIZED POLYBUTADIENE ELASTOMER, AND AN INORGANIC FILLER; FOR POTTING SEMICONDUCTORS | SUMITOMO BAKELITE CO., LTD. (JP) | 2000-10-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11730717-B1 | Melanin-inspired antimicrobial | TYR, MCHR1, EEA1 | GABRA1 879/4885GABRB2 1370/4885SLC6A2 1177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.